High‐sensitivity C‐reactive protein measurements in patients with non‐arteritic anterior ischaemic optic neuropathy: a clue to the presence of a microinflammatory response

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Acta ophthalmologica

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1755-3768.2008.01199.xPMID 18577187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events

  2006cited by this paper
• C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population

  2006cited by this paper
• Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease.

  2005cited by this paper
• Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation.

  2005cited by this paper
• Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis

  2005cited by this paper
• Statins for atherosclerosis--as good as it gets?

  2005cited by this paper
• Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model.

  2005cited by this paper
• Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals.

  2005cited by this paper
• Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation.

  2005cited by this paper
• Non-arteritic ischaemic optic neuropathy (NAION) in patients under 50 years of age.

  2005cited by this paper
• Exercise training prevents cardiac dysfunction and altered sarcoplasmic calcium reuptake in a genetic model of cardiomyopathy induced by sympathetic hyperactivity

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Clinical Use of Inflammatory Markers in Patients With Cardiovascular Diseases A Background Paper

  2004cited by this paper
• Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences.

  2004cited by this paper
• Role of Thrombocytosis in Diagnosis of Giant Cell Arteritis and Differentiation of arteritic from Non-Arteritic Anterior Ischemic Optic Neuropathy

  2004cited by this paper
• Effect of Short-Term Aspirin Use on C-Reactive Protein

  2004cited by this paper
• C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis.

  2004cited by this paper
• Inflammation and Atherosclerosis

  2004cited by this paper
• C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?

  2004cited by this paper
• Leukocyte count and coronary heart disease: implications for risk assessment.

  2004influential reference
• Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels.

  2003cited by this paper
• C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke

  2003cited by this paper
• Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

  2002influential reference
• On evolutionary biology, inflammation, infection, and the causes of atherosclerosis.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.

  2001cited by this paper
• Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease.

  2000influential reference
• Acute-phase proteins and other systemic responses to inflammation.

  1999cited by this paper
• Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

  1999cited by this paper
• Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.

  1999cited by this paper
• Incidence of Nonarteritic and Arteritic Anterior Ischemic Optic Neuropathy: Population‐Based Study in the State of Missouri and Los Angeles County, California

  1994cited by this paper
• Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors.

  1987cited by this paper
• Anterior ischemic optic neuropathy of the young.

  1983cited by this paper
• Anterior ischemic optic neuropathy of the young.

  1983cited by this paper
• Anterior ischemic optic neuropathy.

  1981cited by this paper
• Recommendation of measurement of erythrocyte sedimentation rate of human blood.

  1977cited by this paper
• Anterior Ischemic Optic Neuropathy

  1975cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper
• [Rapid method for the determination of fibrinogen].

  1957cited by this paper

• Exploring the role of inflammation in age-related macular degeneration: new insights and implications for future therapies

  2025influential citation
• Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis

  2022cites this paper
• Risk Factors for Non-arteritic Anterior Ischemic Optic Neuropathy: A Large Scale Meta-Analysis

  2021cites this paper
• The Usefulness of the Erythrocyte Sedimentation Rate and C-reactive Protein for the Differential Diagnosis of Non-Arteritic Anterior Ischemic Optic Neuropathy in the Era of Microinflammation

  2020cites this paper
• Distinguishing non arteritic ischemic optic neuropathy and optic neuritis with serum Vitamin B12, ferritin and folic acid levels.

  2018cites this paper
• Monocyte/HDL Ratio and Lymphocyte/Monocyte Ratio in Patients with Pseudoexfoliation Syndrome

  2018cites this paper
• Aqueous Humor Cytokines in Patients With Acute Nonarteritic Anterior Ischemic Optic Neuropathy.

  2017cites this paper
• Associations between thrombophilic risk factors and determinants of atherosclerosis and inflammation in patients with non-arteritic anterior ischaemic optic neuropathy

  2016cites this paper
• Vascular Diseases of the Optic Nerve: Internal Medicine Aspects

  2016cites this paper
• Treatment of anterior ischemic optic neuropathy: Clues from the bench

  2014cites this paper
• Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy

  2014cites this paper
• Magnetic Resonance Imaging Findings of Elevated Intracranial Pressure in Cerebral Venous Thrombosis Versus Idiopathic Intracranial Hypertension with Transverse Sinus Stenosis

  2013cites this paper
• The Association between Diabetes Mellitus and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis

  2013cites this paper
• High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome.

  2013cites this paper
• High-sensitivity C-reactive protein measurements in patients with non-arteritic anterior ischaemic optic neuropathy: a clue to the presence of a microinflammatory response

  2010cites this paper
• Systemic High-sensitivity C-reactive Protein Level in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma

  2010cites this paper
• Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy

  2009cites this paper